[Hepato-biliary complications of estro-progestin therapy].
A brief account of the most frequently observed side-effects of the protracted administration of oestroprogestinic substances is followed by a detailed explanation of the damage they may cause to the hepatobiliary apparatus: cholestatic icterus; cholesterolic biliary lithiasis; benign and malignant liver neoplasias. Reference is made to the liver diagnosis problems the practitioner may encounter when dealing with patients treated with these substances. Stress is laid on the need for close monitoring of tolerance and the possible effects of oestroprogestinic management on liver and bile function.
D006528:Carcinoma, Hepatocellular / Q000139:chemically induced; D002769:Cholelithiasis / Q000139:chemically induced*; D004334:Drug Administration Schedule; D004967:Estrogens / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007565:Jaundice / Q000139:chemically induced*; D008113:Liver Neoplasms / Q000139:chemically induced*; D010382:Peliosis Hepatis / Q000139:chemically induced; D011372:Progestins / Q000009:adverse effects*
D004967:Estrogens; D011372:Progestins
Complicanze epato-biliari della terapia estro-progestinica.